Alum-adjuvanted H5N1 whole virion inactivated vaccine (WIV) induced IgG1 and IgG4 antibody responses in young children
- PMID: 23102974
- DOI: 10.1016/j.vaccine.2012.10.006
Alum-adjuvanted H5N1 whole virion inactivated vaccine (WIV) induced IgG1 and IgG4 antibody responses in young children
Abstract
IgG subclass antibody responses are not fully understood. Alum-adjuvanted H5N1whole virion inactivated vaccine (WIV), a genetically reassortant vaccine seed strain originating from H5N1/A/Vietnam/1194/2004 and PR-8, induced significantly stronger antibody responses in neutralizing antibodies in children. In this report, IgG subclass antibody responses were investigated, and most serum samples were positive for IgG1 antibody before immunization. A significant response (more than 4-fold increase) of IgG1 antibody was observed in 67/193 (34.7%) and that of gG4 antibodies in 42/193(21.8%). Children <4 years of age showed a significant increase in IgG subclass antibodies but those ≥4 years showed lower responses. Alum- adjuvanted H5N1WIV induced an efficient immune response in young children especially <4 years.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Similar articles
-
Alum-adjuvanted H5N1 whole virion inactivated vaccine (WIV) enhanced inflammatory cytokine productions.Vaccine. 2012 Jun 6;30(26):3885-90. doi: 10.1016/j.vaccine.2012.04.004. Epub 2012 Apr 13. Vaccine. 2012. PMID: 22507655
-
Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults.Vaccine. 2008 Aug 5;26(33):4160-7. doi: 10.1016/j.vaccine.2008.05.077. Epub 2008 Jun 13. Vaccine. 2008. PMID: 18599164 Clinical Trial.
-
Antibody persistence after 2-dose priming and booster response to a third dose of an inactivated, adjuvanted, whole-virion H5N1 vaccine.J Infect Dis. 2009 Jan 15;199(2):184-7. doi: 10.1086/595832. J Infect Dis. 2009. PMID: 19067606 Clinical Trial.
-
The avian influenza vaccine Emerflu. Why did it fail?Expert Rev Vaccines. 2015;14(8):1125-34. doi: 10.1586/14760584.2015.1059760. Epub 2015 Jun 22. Expert Rev Vaccines. 2015. PMID: 26098721 Review.
-
Quantitative review of antibody response to inactivated seasonal influenza vaccines.Influenza Other Respir Viruses. 2012 Jan;6(1):52-62. doi: 10.1111/j.1750-2659.2011.00268.x. Epub 2011 Jun 13. Influenza Other Respir Viruses. 2012. PMID: 21668661 Free PMC article. Review.
Cited by
-
Augmentation of vaccine-induced humoral and cellular immunity by a physical radiofrequency adjuvant.Nat Commun. 2018 Sep 12;9(1):3695. doi: 10.1038/s41467-018-06151-y. Nat Commun. 2018. PMID: 30209303 Free PMC article.
-
Synergistic effect of non-neutralizing antibodies and interferon-γ for cross-protection against influenza.iScience. 2021 Sep 15;24(10):103131. doi: 10.1016/j.isci.2021.103131. eCollection 2021 Oct 22. iScience. 2021. PMID: 34622175 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials